Table 1 Odds ratios corresponding to quartiles defined using the internal validation breast cancer dataset.
Quantile | Control | Cancer | OR (unadjusted) | OR (adjusted) |
---|---|---|---|---|
Breast cancer internal validation | ||||
(−1.53, −0.58) | 75 | 2 | 1.00 (reference) | 1.00 (reference) |
(−0.58, −0.28) | 74 | 5 | 2.42 (0.48,19.25) | 2.29 (0.45, 17.15) |
(−0.28, 0.07) | 74 | 17 | 8.01 (2.17,56.31) | 8.47 (2.23, 55.81) |
(0.07, 1.62) | 74 | 88 | 41.11 (12.33,274.77) | 41.73 (12.2, 262.62) |
Breast cancer external validation | ||||
(−1.53, −0.58) | 58 | 8 | 1.00 (reference) | 1.00 (reference) |
(−0.58, −0.28) | 69 | 8 | 0.84 (0.29,2.46) | 0.89 (0.3, 2.67) |
(−0.28, 0.07) | 50 | 14 | 2.00 (0.78,5.46) | 2.57 (0.95, 7.51) |
(0.07, 1.62) | 48 | 83 | 12.19 (5.62,29.86) | 15.67 (6.59, 42.38) |
Ovarian cancer | ||||
(−1.53, −0.58) | 75 | 30 | 1.00 (reference) | 1.00 (reference) |
(−0.58, −0.28) | 74 | 31 | 1.05 (0.57,1.91) | 0.93 (0.48, 1.79) |
(−0.28, 0.07) | 74 | 51 | 1.72 (0.99,3.01) | 1.16 (0.61, 2.19) |
(0.07, 1.62) | 74 | 130 | 4.36 (2.64,7.36) | 3.27 (1.9, 5.68) |
Endometrial cancer | ||||
(−1.53, −0.58) | 75 | 39 | 1.00 (reference) | 1.00 (reference) |
(−0.58, −0.28) | 74 | 42 | 1.09 (0.63,1.88) | 0.89 (0.46, 1.72) |
(−0.28, 0.07) | 74 | 61 | 1.58 (0.95,2.66) | 0.74 (0.36, 1.49) |
(0.07, 1.62) | 74 | 75 | 1.94 (1.18,3.23) | 0.80 (0.41, 1.53) |